THE COMPARISON BETWEEN CHINA AND THE UNITED STATE (US) RIVALRY IN COVID-19 VACCINE INDUSTRY: AN EXMINATION FROM INDONESIAN PERSPECTIVE

Abstract

The trade war between the US and China has not ended so far; coupled with the outbreak of Covid-19 outbreak, the two countries are increasingly demonstrating their hegemonic power in their way; China, with its Belt Road Initiative, and the US, which has long been the ruler of the world. We can see vaccine competition between the US and China from the many vaccine companies in the two countries circulating in the world. This study aims to analyze Indonesia's response to vaccine competition between China and America using the hegemonic theory. In this study, the authors used qualitative methods. The author argues that by using free and active Indonesia Foreign Policy from Indonesia's point of view, Indonesia's response to the two countries is still neutral, such as how Indonesia responds to the competition between the two countries, starting from the Vaccine Cooperation with Russia, making its vaccines, to Indonesia's position as a Non-Aligned country. However, it does not rule out the possibility that Indonesia will not receive the full aid quota from the two countries.